Environmental risk assessment of human pharmaceuticals in the European union: a case study with the β-blocker atenolol

Küster A, Alder AC, Escher BI, Duis K, Fenner K, Garric J, Hutchinson TH, Lapen DR, Péry A, Römbke J, Snape J, Ternes T, Topp E, Wehrhan A & Knacker T
Choose the citation style.
Küster, A., Alder, A. C., Escher, B. I., Duis, K., Fenner, K., Garric, J., … Knacker, T. (2010). Environmental risk assessment of human pharmaceuticals in the European union: a case study with the β-blocker atenolol. Integrated Environmental Assessment and Management, 6(1), 514-523. https://doi.org/10.1897/IEAM_2009-050.1